Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
prolong ejaculation.
Popular Articles

Media Looks At County-Level HIV, AIDS Map Data
Major population centers such as those in New York and California have the highest numbers of HIV cases, however, many of the areas that have the highest rates of people with HIV are in the South, according to data from an online mapping tool launched by the National Minority Quality Forum yesterday, the AP/Minneapolis Star Tribune reports. The map, which is the first tool of its kind to look at HIV and AIDS cases on a county level, is based on 2006 data collected from states and cross-checked with CDC data. According to the mapping tool, of the 48 counties with the highest HIV prevalence rates, 25 are in Georgia. In addition, Florida, Georgia, South Carolina and Virginia have the highest prevalence rates for HIV cases that have progressed to AIDS (Stobbe, AP/Minneapolis Star Tribune, 6/22). In Virginia, Richmond, Petersburg and Norfolk were among the nation"s urban areas hardest hit by HIV/AIDS (Smith, Richmond Times-Dispatch, 6/23). Three metro counties in Kansas City, Mo., have HIV and AIDS rates that are higher than about 80 percent of counties nationwide, according to the data, NBC Action News reports (Ptacek, NBC Action News, 6/22).
generic viagra
MPs Debate 'Blatant Discrimination' Of Oyxgen Users, UK
Yesterday MPs debated the discrimination that people with a lung condition can experience when they travel on planes. People with lung conditions such as Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Hypertension often require additional supplementary oxygen due to the low levels of oxygen in their blood. However, due to the policies set by airline companies, it is both expensive and difficult for people who need supplementary oxygen to plan and use air travel.
News of the day
Protein Linked To Mental Retardation Controls Synapse Maturation, Plasticity, CSHL Team Finds
Oligophrenin-1, a Rho-GTPase-activating protein, stabilizes postsynaptic AMPA receptors
Diagnostics

2009/044 NICE Issues Final Guidance On The Use Of Rituximab For First Line Chronic Lymphocytic Leukaemia

The National Institute for Health and Clinical Excellence (NICE) has today (22 July) published guidance on the use of rituximab for the first line treatment of chronic lymphocytic leukaemia. The guidance recommends that rituximab should be considered asa possible first treatment for people with chronic lymphocytic leukaemia who are able to take fludarabine in combination with cyclophosphamide. Rituximab should only be used in combination with fludarabine and cyclophosphamide. Rituximab is not recommended in combination with any other chemotherapy agents as a first treatment for chronic lymphocytic leukaemia. Chronic lymphocytic leukaemia is the most common form of adult leukaemia and is a cancer of the white blood cells (lymphocytes). The cancerous lymphocytes multiply in an uncontrolled way and stop normal white blood cells, red blood cells and platelets (blood fragments that have a role in the clotting of blood) from working properly. Dr Carole Longson, NICE Health Technology Evaluation Centre Director said: "After looking at all of the available evidence the independent Appraisal Committee concluded that rituximab, when used as a first line treatment for people with with chronic lymphocytic leukaemia who are able to take fludarabine in combination with cyclophosphamide, represented an effective use of NHS res. This important guidance increases the treatment options available to people with this condition, wherever they live in England and Wales." NICE


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009